pCPA

Accelerating drug access in Canada: New pathways from the pCPA and Province of Ontario

By Sarah Pennington, Paul Jorgensen & Kristin Wall on November 4, 2025

In October 2025, the pan-Canadian Pharmaceutical Alliance (pCPA) and the Government of Ontario announced new pathways to accelerate the funding of new drugs for Canadians. Canada currently ranks last among G7 countries in providing patients with timely access…

Drug price negotiations: pCPA Temporary Access Process launched

By Sarah Pennington, Kristin Wall & Paul Jorgensen on April 10, 2024

The pan-Canadian Pharmaceutical Alliance (pCPA) has launched its Temporary Access Process (pTAP) to facilitate early market access to new drugs that were assessed under the time-limited reimbursement recommendation (TLR) pathway at the Canada Drug…

Pharma in Brief

pCPA

Accelerating drug access in Canada: New pathways from the pCPA and Province of Ontario

Drug price negotiations: pCPA Temporary Access Process launched

About

Topics

Archives